Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer's Serenex Acquisition Adds Fuel to Heat Shock Fire

Related Content

The $100 Million IND

Nov 01 2006

A New, Compelling Reason to Target Hsp90 in Tumor Cells

Nov 01 2007

Biopharma VC Exits 2005-2007: Cheap IPOs, Expensive Acquisitions

Jan 01 2008

Serenex Inc.

May 01 2003

NovaCardia & Domain: New-Model Spec Pharma Investing

Sep 01 2007

Related Companies

Pfizer Inc.

Biogen, Inc.

MedImmune LLC

AstraZeneca PLC

Infinity Pharmaceuticals, Inc.

Takeda Pharmaceutical Co. Ltd.

Madrigal Pharmaceuticals, Inc.

Duke University School of Medicine

GSK plc

Johnson & Johnson

Novartis AG

Ligand Pharmaceuticals, Inc.

National Institutes of Health

National Cancer Institute

Additional Topics

Strategy Business Strategies BioPharmaceutical

More from Business Strategy

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window